Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2025
Phase 2 trial of ponatinib in patients with metastatic gastrointestinal stromal tumor following failure or intolerance of prior therapy with imatinib (POETIG trial)Johanna Falkenhorst, Phillipp Ivanyi, Tom Schulz, et al.
BMC Cancer|June 4, 2020
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)Joseph Tintelnot, Eray Goekkurt, Mascha Binder, et al.
The Lancet. Gastroenterology & Hepatology|June 13, 2024
Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trialArndt Vogel, Anna Saborowski, Patrick Wenzel, et al.
JAMA Oncology|March 24, 2017
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical TrialHeikki Joensuu, Eva Wardelmann, Harri Sihto, et al.
International Journal of Cancer|June 10, 2026
Plasma PlGF as a Potential Biomarker in Ramucirumab-Based Second-Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS TrialJurek Hille, Sylvie Lorenzen, Claudia Pauligk, et al.
Frontiers in Oncology|January 31, 2025
Long-term disease control in dedifferentiated liposarcoma: a case report on trabectedin priming followed by PD-1 inhibitionJohannes M Waldschmidt, Lukas Haug, Christine Riedhammer, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 19, 2023
Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic reviewParaskevi Danai Veltsista, Eva Oberacker, Adela Ademaj, et al.
International Journal of Cancer|March 6, 2024
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapyMichael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, et al.
International Journal of Cancer|December 13, 2025
Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study)Thorsten O Goetze, Salah-Eddin Al-Batran, Ruediger Liersch, et al.
Cancers|November 11, 2022
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV TrialViktor Grünwald, Daniel Pink, Gerlinde Egerer, et al.
Pageof 7